DRUGS & PHARMA
Biocon plans a unit in Malaysia

Biocon plans a unit in Malaysia

Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research and development unit to manufacture high-end biosimilars and biopharmaceuticals. The company... Full Story

Biological E to invest ₹1,800 crore in Hyderabad to expand vaccine manufacturing capacity.

Biological E will invest over ₹1,800 crore for expanding manufacturing capacity of vaccines along with generic Injectables and Research and Development... Full Story

Browse All News by Date

Chemo Pharma to invest ₹100 cr in Hyderabad facility.

Spanish multinational company Chemo Pharma has announced an investment of ₹100 crore to establish a second line in their production... Full Story

More Top Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2022

Technology Partner - Pairscript Software